Certified by Founder Lodge
3B Future Health Fund I & II
Germany - Luxembourg INVESTOR
1 Disclosed Funding Rounds $5,000,000
5 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
3B Future Health Fund is an investment fund with focus on early-stage investment opportunities in areas of high unmet patient need, mainly oncology and rare disease therapeutics.
We focus o
| Company | Date | Round | Raised |
|---|---|---|---|
 Geneos Therapeutics | April, 13 ,2023 | Series A | $5,000,000 |
 OncoResponse | May, 19 ,2023 | Unknown | $14,000,000 |
 Fore Biotherapeutics | August, 25 ,2023 | Series D | $75,000,000 |
 NeoPhore Ltd | February, 02 ,2024 | Series B | $12,245,712 |
 Epsilogen Ltd | September, 10 ,2024 | Series B | $16,370,899 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
